519 related articles for article (PubMed ID: 32846611)
21. The trinity of COVID-19: immunity, inflammation and intervention.
Tay MZ; Poh CM; Rénia L; MacAry PA; Ng LFP
Nat Rev Immunol; 2020 Jun; 20(6):363-374. PubMed ID: 32346093
[TBL] [Abstract][Full Text] [Related]
22. An updated insight into the molecular pathogenesis, secondary complications and potential therapeutics of COVID-19 pandemic.
Jamwal S; Gautam A; Elsworth J; Kumar M; Chawla R; Kumar P
Life Sci; 2020 Sep; 257():118105. PubMed ID: 32687917
[TBL] [Abstract][Full Text] [Related]
23. Probiotics/Prebiotics in Viral Respiratory Infections: Implication for Emerging Pathogens.
Heidari Z; Tajbakhsh A; Gheibihayat SM; Moattari A; Razban V; Berenjian A; Savardashtaki A; Negahdaripour M
Recent Pat Biotechnol; 2021 Oct; 15(2):112-136. PubMed ID: 33874878
[TBL] [Abstract][Full Text] [Related]
24. An overdose surge will compound the COVID-19 pandemic if urgent action is not taken.
Wakeman SE; Green TC; Rich J
Nat Med; 2020 Jun; 26(6):819-820. PubMed ID: 32555514
[TBL] [Abstract][Full Text] [Related]
25. SARS-CoV-2-Indigenous Microbiota Nexus: Does Gut Microbiota Contribute to Inflammation and Disease Severity in COVID-19?
Chattopadhyay I; Shankar EM
Front Cell Infect Microbiol; 2021; 11():590874. PubMed ID: 33791231
[TBL] [Abstract][Full Text] [Related]
26. Beyond probiotic legend: ESSAP gut microbiota health score to delineate SARS-COV-2 infection severity.
Hegazy M; Ahmed Ashoush O; Tharwat Hegazy M; Wahba M; Lithy RM; Abdel-Hamid HM; Ahmed Abd Elshafy S; Abdelfatah D; El-Din Ibrahim MH; Abdelghani A
Br J Nutr; 2022 Apr; 127(8):1180-1189. PubMed ID: 34096487
[TBL] [Abstract][Full Text] [Related]
27. Coronavirus Disease 2019 (COVID-19) and Immune-Engaging Cancer Treatment.
Abid MB; Mughal M; Abid MA
JAMA Oncol; 2020 Oct; 6(10):1529-1530. PubMed ID: 32433719
[No Abstract] [Full Text] [Related]
28. Gut microbiome and anti-viral immunity in COVID-19.
Rossini V; Tolosa-Enguis V; Frances-Cuesta C; Sanz Y
Crit Rev Food Sci Nutr; 2024; 64(14):4587-4602. PubMed ID: 36382631
[TBL] [Abstract][Full Text] [Related]
29. [Management of COVID-19: the Zhejiang experience].
Xu K; Cai H; Shen Y; Ni Q; Chen Y; Hu S; Li J; Wang H; Yu L; Huang H; Qiu Y; Wei G; Fang Q; Zhou J; Sheng J; Liang T; Li L
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 Feb; 49(2):147-157. PubMed ID: 32391658
[TBL] [Abstract][Full Text] [Related]
30. Hypertension and SARS-CoV-2 infection: is inflammation the missing link?
Bartoloni E; Perricone C; Cafaro G; Gerli R
Cardiovasc Res; 2020 Nov; 116(13):e193-e194. PubMed ID: 32966547
[No Abstract] [Full Text] [Related]
31. The probiotic
Bozkurt HS; Quigley EM
Int J Immunopathol Pharmacol; 2020; 34():2058738420961304. PubMed ID: 33103512
[TBL] [Abstract][Full Text] [Related]
32. Potential Causes and Consequences of Gastrointestinal Disorders during a SARS-CoV-2 Infection.
Trottein F; Sokol H
Cell Rep; 2020 Jul; 32(3):107915. PubMed ID: 32649864
[TBL] [Abstract][Full Text] [Related]
33. COVID-19 influenced gut dysbiosis, post-acute sequelae, immune regulation, and therapeutic regimens.
Raj ST; Bruce AW; Anbalagan M; Srinivasan H; Chinnappan S; Rajagopal M; Khanna K; Chandramoorthy HC; Mani RR
Front Cell Infect Microbiol; 2024; 14():1384939. PubMed ID: 38863829
[TBL] [Abstract][Full Text] [Related]
34. The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications.
Scaldaferri F; Ianiro G; Privitera G; Lopetuso LR; Vetrone LM; Petito V; Pugliese D; Neri M; Cammarota G; Ringel Y; Costamagna G; Gasbarrini A; Boskoski I; Armuzzi A
Inflamm Bowel Dis; 2020 Aug; 26(9):1306-1314. PubMed ID: 32720978
[TBL] [Abstract][Full Text] [Related]
35. Oncology Care Delivery in the COVID-19 Pandemic: An Opportunity to Study Innovations and Outcomes.
Cinar P; Cox J; Kamal A; Bickel K; Krzyzanowska M; Armitage J; Ganti AK; Ward J; Wong S; Lonial S; Bosserman L
JCO Oncol Pract; 2020 Aug; 16(8):431-434. PubMed ID: 32463764
[No Abstract] [Full Text] [Related]
36. Severe COVID-19 disease and thromboinflammation.
Jerjes-Sánchez C
Arch Cardiol Mex; 2020; 90(3):257-258. PubMed ID: 32952161
[No Abstract] [Full Text] [Related]
37. Inflammation and thrombosis in patients with COVID-19: A prothrombotic and inflammatory disease caused by SARS coronavirus-2.
Pamukçu B
Anatol J Cardiol; 2020 Oct; 24(4):224-234. PubMed ID: 33001051
[TBL] [Abstract][Full Text] [Related]
38. Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome.
Villapol S
Transl Res; 2020 Dec; 226():57-69. PubMed ID: 32827705
[TBL] [Abstract][Full Text] [Related]
39. Modifying Practices in GI Oncology in the Face of COVID-19: Recommendations From Expert Oncologists on Minimizing Patient Risk.
Lou E; Beg S; Bergsland E; Eng C; Khorana A; Kopetz S; Lubner S; Saltz L; Shankaran V; Zafar SY
JCO Oncol Pract; 2020 Jul; 16(7):383-388. PubMed ID: 32352884
[No Abstract] [Full Text] [Related]
40. Management of Febrile Neutropenia Associated With SARS-CoV-2 Infection in a Patient With Cancer.
Figuero-Pérez L; Olivares-Hernández A; Escala-Cornejo RA; Cruz-Hernández JJ
JCO Oncol Pract; 2020 Jun; 16(6):348-349. PubMed ID: 32369410
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
